netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 3: Respiratory system - Full Section
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Useful Links

03.01 Bronchodilators
03.01.01 Adrenoceptor agonists
03.01.01.01 Selective Beta2 agonists
Short-acting beta2 agonists
Long-acting beta2 agonists
03.01.01.02 Other adrenoceptor agonists
03.01.02 Antimuscarinic bronchodilators
Short Acting Anti-muscarinic Bronchodilators
Long Acting Anti-muscarinic Bronchodilators
03.01.03 Theophylline
03.01.04 Compound bronchodilator preparations
03.01.05 Peak flow meters, inhaler devices and nebulisers
Peak flow meters
Drug delivery devices
03.02 Corticosteroids
03.02.01 Inhaled Corticosteroids
03.02.02 Combination products (ICS+LABA) for asthma
Low dose
Moderate dose
High dose
03.02.03 Combination products (ICS+LABA) for COPD
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists
03.03.01 Cromoglicate and related therapy
03.03.02 Leukotriene receptor antagonists
03.03.03 Phosphodiesterase type-4 inhibitors
03.04 Antihistamines, hyposensitisation, and allergic emergencies
03.04.01 Antihistamines
Non-sedating antihistamines
Sedating antihistamines
03.04.02 Allergen Immunotherapy
Omalizumab, mepolizumab and other therapies
03.04.03 Allergic emergencies
Anaphylaxis
Angioedema
03.05 Respiratory stimulants and pulmonary surfactants
03.05.01 Respiratory stimulants
03.05.02 Pulmonary surfactants
03.06 Oxygen
03.07 Mucolytics
Dornase alfa
Hypertonic Sodium Chloride
Mannitol
03.08 Aromatic inhalations
03.09 Cough preparations
03.09.01 Cough suppressants
Palliative care
03.09.02 Expectorant and demulcent cough preparations
03.10 Systemic nasal decongestants
03.11 Antifibrotics
03.12 Miscellaneous preparations
03.13 Triple combination therapy inhalers (ICS + LABA + LAMA) for adults with COPD
netFormulary